Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Elisabet E Gardarsdottir"'
Autor:
Asgeir Sigurdsson, Hakon Jonsson, Arnaldur Gylfason, Gardar Sveinbjornsson, Emil A Thorarensen, Gudmundur L. Norddahl, S Hjortur Kristjansson, Louise le Roux, Jona Saemundsdottir, Gudny A. Arnadottir, Kjartan R Gudmundsson, Steinunn Kristjánsdóttir, Gisli Masson, Lovisa Bjork Olafsdottir, Magnus Gottfredsson, Marianna Thordardottir, Elisabet E Gardarsdottir, Asgeir O. Arnthorsson, Unnur Thorsteinsdottir, Run Fridriksdottir, Solvi Rognvaldsson, Thora R Gunnarsdottir, Gudrun Sigmundsdottir, Kamilla S Josefsdottir, Droplaug N Magnusdottir, Maney Sveinsdottir, Anna M. Kristinsdottir, Olafur T. Magnusson, Kristbjorg Gunnarsdottir, Runolfur Palsson, Steinunn Gudmundsdottir, Martin I. Sigurdsson, Erna V. Ivarsdottir, Arna B Agustsdottir, Bjarni Thorbjornsson, Jonas Berglund, Gudmundur Georgsson, Ingileif Jonsdottir, Alma D. Möller, Daniel F. Gudbjartsson, Agnar Helgason, Hilma Holm, Páll Melsted, Karl G. Kristinsson, Frosti Jonsson, Olafia S Gretarsdottir, Thorolfur Gudnason, Patrick Sulem, Elias Eythorsson, Brynja Thorsteinsdottir, Kristin E Sveinsdottir, Berglind Eiriksdottir, Dadi Helgason, Kolbrun Birgisdottir, Kari Stefansson, Mar Kristjansson, Ragnar Freyr Ingvarsson, Brynjar O. Jensson, Kristbjorg Bjarnadottir, Margret B. Andresdottir, Thordur Kristjansson, Aslaug Jonasdottir
Publikováno v:
The New England Journal of Medicine
New England Journal of Medicine
New England Journal of Medicine
Background Little is known about the nature and durability of the humoral immune response to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods We measured antibodies in serum samples from 30,576 persons in Iceland,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5719a318bd07d2848f0d9c8dc143fdac
http://europepmc.org/articles/PMC7494247
http://europepmc.org/articles/PMC7494247
Autor:
Daniel F. Gudbjartsson, Louise le Roux, Kamilla S Josefsdottir, Kjartan R Gudmundsson, Berglind Eiriksdottir, Emil A Thorarensen, Olafia S Gretarsdottir, Hilma Holm, Run Fridriksdottir, Gardar Sveinbjornsson, Aslaug Jonasdottir, Elisabet E Gardarsdottir, Brynjar O. Jensson, Gudmundur Georgsson, Maney Sveinsdottir, Frosti Jonsson, Patrick Sulem, Páll Melsted, Arna B Agustsdottir, Droplaug N Magnusdottir, Thora R Gunnarsdottir, Karl G. Kristinsson, Jona Saemundsdottir, Ingileif Jonsdottir, Arthur Löve, Asgeir Sigurdsson, Thordur Kristjansson, Gudmundur L. Norddahl, Unnur Thorsteinsdottir, Hakon Jonsson, Arnaldur Gylfason, Gudrun Sigmundsdottir, Kari Stefansson, Alma D. Möller, Bjarni Thorbjornsson, Gisli Masson, Agnar Helgason, Kristin E Sveinsdottir, Olafur T. Magnusson, Thorolfur Gudnason
Publikováno v:
The New England Journal of Medicine
New England Journal of Medicine
New England Journal of Medicine
Background During the current worldwide pandemic, coronavirus disease 2019 (Covid-19) was first diagnosed in Iceland at the end of February. However, data are limited on how SARS-CoV-2, the virus that causes Covid-19, enters and spreads in a populati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbf22ef58290304ffe2805abab4a430f
http://europepmc.org/articles/PMC7175425
http://europepmc.org/articles/PMC7175425
Autor:
Olafia S Gretarsdottir, Elisabet E Gardarsdottir, Gudmundur Georgsson, Maney Sveinsdottir, Thora R Gunnarsdottir, Páll Melsted, Bjarni Thorbjornsson, Ingileif Jonsdottir, Arnaldur Gylfason, Kjartan R Gudmundsson, Arthur Löve, Gisli Masson, Jona Saemundsdottir, Hilma Holm, Brynjar O. Jensson, Aslaug Jonasdottir, Kamilla S Josefsdottir, Daniel F. Gudbjartsson, Alma D. Möller, Thordur Kristjansson, Gardar Sveinbjornsson, Gudmundur L. Norddahl, Run Fridriksdottir, Gudrun Sigmundsdottir, Kari Stefansson, Arna B Agustsdottir, Karl G. Kristinsson, Thorolfur Gudnason, Hakon Jonsson, Patrick Sulem, Unnur Thorsteinsdottir, Kristin E Sveinsdottir, Droplaug N Magnusdottir, Berglind Eiriksdottir, Asgeir Sigurdsson, Frosti Jonsson, Emil A Thorarensen, Louise le Roux, Olafur Th Magnusson, Agnar Helgason
BACKGROUNDLimited data exist on how SARS-CoV-2 enters and spreads in the general population.METHODSWe used two strategies for SARS-CoV-2 testing: targeted testing of high-risk individuals (n=4,551) and a population screening (n=5,502). We sequenced S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f377c8c5fd16f9fecff444a344c2fc3
https://doi.org/10.1101/2020.03.26.20044446
https://doi.org/10.1101/2020.03.26.20044446
